Waters
FDA Rule on Laboratory-Developed Tests Could Shake up Clinical Mass Spectrometry Space
The rule could boost Roche's planned launch of an FDA-cleared mass spec system while requiring other vendors to rethink their clinical strategies.
With the agency planning to issue a proposed rule on LDTs in August, ADLM members look to use the public comment period to express opposition to the effort.
UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies
The investment bank also released an updated rating for Danaher as it expanded its coverage of the life science tools and diagnostic market.
The companies said that they envisioned the test, which is currently RUO, as potentially part of a mass spectrometry-based respiratory virus panel.
In Brief This Week: PerkinElmer, Waters, Celcuity, and More
PerkinElmer reduced its headcount by 109 employees in 2018 as a result of restructuring actions, it said in its Form 10-K filed with the US Securities and Exchange Commission this week.